BSEMediumNeutral
Announced Wed, 14 May · 19:50 IST

Appointment of Non-Executive Independent Director

Management Changes View source PDF
Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

J. B. Chemicals & Pharmaceuticals Limited has appointed Mr. Ashwani Kumar Puri (DIN: 00160662) as an additional Non-Executive Independent Director on its board, effective May 14, 2025. Mr. Puri is a Chartered Accountant and Certified Management Accountant with over 33 years of experience at PwC, including 22 years as a partner. He previously led PwC's India Advisory Services and served on its India and Global Advisory Leadership Teams. He is currently an independent director on the boards of Titan Company, Travel Food Services, and Healthium Medtech. He will hold office until the next annual general meeting and is not related to any existing director on the board.

Likely market impact

This is a routine governance update with no immediate impact on shareholders or stock price. Adding a seasoned independent director with strong audit, advisory, and governance credentials may strengthen board oversight and corporate governance practices going forward.